HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiseptic Log Reduction Criteria Should Stand, NDAC Recommends

This article was originally published in The Rose Sheet

Executive Summary

Current log reduction criteria to measure the efficacy of topical antiseptic products should not be reduced due to a lack of "compelling" data to support revising the standards, FDA's Nonprescription Drugs Advisory Committee concluded during a March 23 meeting in Gaithersburg, Md

You may also be interested in...



NDAC To Assess Risks, Efficacy Of Antiseptic Hand Wash Products

The risks and benefits of consumer antibacterial hand and body wash products will be considered by the Center for Drug Evaluation & Research Nonprescription Drugs Advisory Committee at a meeting slated for Oct. 20-21

NDAC To Assess Risks, Efficacy Of Antiseptic Hand Wash Products

The risks and benefits of consumer antibacterial hand and body wash products will be considered by the Center for Drug Evaluation & Research Nonprescription Drugs Advisory Committee at a meeting slated for Oct. 20-21

Triclocarban 1.5% Category I Antimicrobial Status Sought By P&G

FDA should include triclocarban at levels of up to 1.5% as a Category I ingredient in its OTC topical antimicrobial products final monograph, Procter & Gamble states in Aug. 19 comments to the agency

Related Content

UsernamePublicRestriction

Register

RS012919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel